Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Tony Daltorio

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year was no different.

What caught my attention was a company I’ve discussed before - AstraZeneca (AZN). The company’s lung (Tagrisso) and breast cancer (Enhertu) drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care for a large number of patients.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.